These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32532545)

  • 1. Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes.
    Donnison T; von Delft A; Brown A; Swadling L; Hutchings C; Hanke T; Chinnakannan S; Barnes E
    Vaccine; 2020 Jul; 38(32):5036-5048. PubMed ID: 32532545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes.
    von Delft A; Donnison TA; Lourenço J; Hutchings C; Mullarkey CE; Brown A; Pybus OG; Klenerman P; Chinnakannan S; Barnes E
    Vaccine; 2018 Jan; 36(2):313-321. PubMed ID: 29203182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice.
    Donnison T; McGregor J; Chinnakannan S; Hutchings C; Center RJ; Poumbourios P; Klenerman P; Drummer HE; Barnes E
    Hepatology; 2022 Oct; 76(4):1190-1202. PubMed ID: 35313015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.
    Wijesundara DK; Gummow J; Li Y; Yu W; Quah BJ; Ranasinghe C; Torresi J; Gowans EJ; Grubor-Bauk B
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes.
    Kelly C; Swadling L; Brown A; Capone S; Folgori A; Salio M; Klenerman P; Barnes E
    Eur J Immunol; 2015 Jan; 45(1):309-16. PubMed ID: 25263407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.
    Atcheson E; Li W; Bliss CM; Chinnakannan S; Heim K; Sharpe H; Hutchings C; Dietrich I; Nguyen D; Kapoor A; Jarvis MA; Klenerman P; Barnes E; Simmonds P
    Hepatology; 2020 Mar; 71(3):794-807. PubMed ID: 31400152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans.
    Kelly C; Swadling L; Capone S; Brown A; Richardson R; Halliday J; von Delft A; Oo Y; Mutimer D; Kurioka A; Hartnell F; Collier J; Ammendola V; Del Sorbo M; Grazioli F; Esposito ML; Di Marco S; Siani L; Traboni C; Hill AV; Colloca S; Nicosia A; Cortese R; Folgori A; Klenerman P; Barnes E
    Hepatology; 2016 May; 63(5):1455-70. PubMed ID: 26474390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
    Swadling L; Capone S; Antrobus RD; Brown A; Richardson R; Newell EW; Halliday J; Kelly C; Bowen D; Fergusson J; Kurioka A; Ammendola V; Del Sorbo M; Grazioli F; Esposito ML; Siani L; Traboni C; Hill A; Colloca S; Davis M; Nicosia A; Cortese R; Folgori A; Klenerman P; Barnes E
    Sci Transl Med; 2014 Nov; 6(261):261ra153. PubMed ID: 25378645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
    Chmielewska AM; Naddeo M; Capone S; Ammendola V; Hu K; Meredith L; Verhoye L; Rychlowska M; Rappuoli R; Ulmer JB; Colloca S; Nicosia A; Cortese R; Leroux-Roels G; Balfe P; Bienkowska-Szewczyk K; Meuleman P; McKeating JA; Folgori A
    J Virol; 2014 May; 88(10):5502-10. PubMed ID: 24599994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviruses vectored hepatitis C virus vaccine cocktails induce broadly specific immune responses against multi-genotypic HCV in mice.
    Luo S; Zhang P; Wang Y; Huang Y; Ma X; Deng Q; Zou P; Wang C; Zhang L; Li Y; Fu Y; Li T; Li C
    Biomed Pharmacother; 2024 Jan; 170():115901. PubMed ID: 38056238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.
    von Delft A; Humphreys IS; Brown A; Pfafferott K; Lucas M; Klenerman P; Lauer GM; Cox AL; Gaudieri S; Barnes E
    Gut; 2016 Jan; 65(1):112-23. PubMed ID: 26092843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-vectored T cell vaccine for hepacivirus shows reduced effectiveness against a CD8 T cell escape variant in rats.
    Hartlage AS; Dravid P; Walker CM; Kapoor A
    PLoS Pathog; 2021 Mar; 17(3):e1009391. PubMed ID: 33735321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.
    Wong JA; Bhat R; Hockman D; Logan M; Chen C; Levin A; Frey SE; Belshe RB; Tyrrell DL; Law JL; Houghton M
    J Virol; 2014 Dec; 88(24):14278-88. PubMed ID: 25275133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity.
    Yusim K; Fischer W; Yoon H; Thurmond J; Fenimore PW; Lauer G; Korber B; Kuiken C
    J Gen Virol; 2010 May; 91(Pt 5):1194-206. PubMed ID: 20053820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved hierarchy of helper T cell responses in a chimpanzee during primary and secondary hepatitis C virus infections.
    Shoukry NH; Sidney J; Sette A; Walker CM
    J Immunol; 2004 Jan; 172(1):483-92. PubMed ID: 14688358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans.
    Esposito I; Cicconi P; D'Alise AM; Brown A; Esposito M; Swadling L; Holst PJ; Bassi MR; Stornaiuolo M; Mori F; Vassilev V; Li W; Donnison T; Gentile C; Turner B; von Delft A; Del Sorbo M; Barra F; Contino AM; Abbate A; Novellino E; Thomsen AR; Christensen JP; Lahm A; Grazioli F; Ammendola V; Siani L; Colloca S; Klenerman P; Nicosia A; Dorrell L; Folgori A; Capone S; Barnes E;
    Sci Transl Med; 2020 Jun; 12(548):. PubMed ID: 32554708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV.
    Chinnakannan SK; Cargill TN; Donnison TA; Ansari MA; Sebastian S; Lee LN; Hutchings C; Klenerman P; Maini MK; Evans T; Barnes E
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32295168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.